Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Open in API
Filings indexed 241 across all filing types
Latest filing 2024-03-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when major shareholders or related parties change their ownership stakes. This corresponds to the 'Major Shareholding Notification' category in the provided schema.
2024-03-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document type is used to report significant changes in share ownership by major shareholders or related parties. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ).
2024-02-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a significant change in financial structure (30% or more change in revenue/profit). This is a standard disclosure requirement for listed companies in Korea to report preliminary financial results or significant deviations before the final audit report is finalized. Since it provides specific financial highlights and performance metrics rather than just announcing the availability of a report, it falls under the 'Earnings Release' category. FY 2023
2024-02-15 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정)(VRN110755의 제1상 임상시험계획 승인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure about clinical trial approval (IND) for the drug VRN110755. It details the approval status from the Taiwan Food and Drug Administration (TFDA). Since this is a specific regulatory disclosure regarding material business operations (clinical trials) that does not fit into the other specialized categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2024-01-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-12-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting results, but rather serves as a formal notice of the procedural step required for the meeting. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS (Regulatory Filings) category.
2023-12-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.